Gil Kristen 4
Research Summary
AI-generated summary
UnitedHealth (UNH) Director Gil Kristen Receives 8-Share Award
What Happened
- Gil Kristen, a director of UnitedHealth Group (UNH), was credited with 8 shares on 2026-06-23 under an award/acquisition (code A). The shares were recorded at $0.00 (no cash paid), so the reported transaction value is $0.
- The filing notes these 8 shares represent dividend equivalents paid on vested deferred stock units; the dividend equivalents are immediately vested and subject to the same terms as the underlying deferred stock units. This is an award/non-cash acquisition rather than an open‑market purchase or sale.
Key Details
- Transaction date: 2026-06-23; Form 4 filed: 2026-06-25 (timely filing).
- Price: $0.00 per share; total reported cash value: $0.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Transaction code: A (award/grant). Footnote F1: dividend equivalents on vested deferred stock units, immediately vested.
- No indication of a sale, option exercise, 10b5-1 plan, or tax-withholding disposition in this entry.
Context
- Dividend-equivalent awards are common for deferred stock plans and are a non-cash compensation event; they don’t by themselves indicate insider buying or selling intent.
- Because this was a small, vested dividend-equivalent award (8 shares), it is typically viewed as routine compensation-related activity rather than a market signal.